Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing Medroxyprogesterone Acetate listed with Health Canada. Original Data : Health Canada Website

Client Email

Product

Medroxyprogesterone Acetate
Megestrol Acetate
CAS 302-23-8
CAS 71-58-9
Canada

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

Coral Medroxyprogesterone Acetate

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Medroxyprogesterone Acetate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 18 USDMF, 6 CEP/COS, 1 JDMF, 5 KDMF, 16 NDC API, 18 Listed Suppliers, $ API Reference Price

31 API Suppliers
18 USDMF
6 CEP/COS
1 JDMF
5 KDMF
16 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

4 API Suppliers

4 API Suppliers

FINISHED DOSAGE FORMULATIONS

153 FDF Dossiers, 41 FDA Orange Book, 48 Europe, 14 Canada, 22 Australia, 17 South Africa, 11 Listed Dossiers

153 FDF Dossiers
41 FDA Orange Book
48 Europe
14 Canada
22 Australia
17 South Africa
11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/ML, INJECTABLE;INJECTION - 150MG/ML

TABLET;ORAL - 10MG
TABLET;ORAL - 2.5MG
TABLET;ORAL - 5MG
INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 400MG/ML
INJECTABLE;INJECTION - 150MG/ML

RELATED EXCIPIENT COMPANIES

1 Evonik, 4 SPI Pharma, 2 Seqens, 3 DKSH, 1 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 27 BASF, 1 Clariant, 3 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 20 Kerry, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 15 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 30 Direct Compression, 28 Coating Systems & Additives, 26 Solubilizers, 23 Controlled & Modified Release, 22 Thickeners and Stabilizers, 19 Lubricants & Glidants, 18 Granulation, 17 Parenteral, 16 Co-Processed Excipients, 16 Topical, 11 Disintegrants & Superdisintegrants, 11 Film Formers & Plasticizers, 11 Taste Masking, 5 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 4 Surfactant & Foaming Agents, 3 Coloring Agents, 3 Rheology Modifiers, 1 API Stability Enhancers

59 Fillers, Diluents & Binders
30 Direct Compression
28 Coating Systems & Additives
26 Solubilizers
23 Controlled & Modified Release
22 Thickeners and Stabilizers
19 Lubricants & Glidants
18 Granulation
17 Parenteral
16 Co-Processed Excipients
16 Topical
11 Disintegrants & Superdisintegrants
11 Film Formers & Plasticizers
11 Taste Masking
5 Emulsifying Agents
5 Chewable & Orodispersible Aids
4 Surfactant & Foaming Agents
3 Coloring Agents
3 Rheology Modifiers
1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 39 Finished Drug Prices

3 US Medicaid Prescriptions
39 Finished Drug Prices

MARKET PLACE

8 APIs, 6 FDF Dossiers

8 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 4 Others

3 EDQM
3 USP
4 Others

$ API Ref.Price (USD/KG) : 920 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

14 All

01 4AA PHARMA INC

02 4PFIZER CANADA ULC

03 3Pharmascience Inc.

04 3TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

14 All

01 11MEDROXYPROGESTERONE ACETATE

02 3Medroxyprogesterone Acetate

filter Dosage Form Reset all filters

14 All

01 1SUSPENSION

02 13TABLET

filter Brand Name Reset all filters

14 All

01 4AA-MEDROXY

02 1DEPO-PROVERA

03 3PMS-MEDROXYPROGESTERONE

04 1PROVERA 10MG TABLETS

05 1PROVERA 2.5MG TABLETS

06 1PROVERA 5MG TABLETS

07 3TEVA-MEDROXYPROGESTERONE

FDF Dossiers
FDA Orange Book
Europe
Canada
Australia
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

AA PHARMA INC

AAPS 2024

Not Confirmed

AA PHARMA INC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEDROXYPROGESTERONE ACETATE

Brand Name : AA-MEDROXY

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100

Approval Date :

Application Number : 2277298

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

PFIZER CANADA ULC

AAPS 2024

Not Confirmed

PFIZER CANADA ULC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEDROXYPROGESTERONE ACETATE

Brand Name : PROVERA 2.5MG TABLETS

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 100/500

Approval Date :

Application Number : 708917

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

03

PFIZER CANADA ULC

AAPS 2024

Not Confirmed

PFIZER CANADA ULC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEDROXYPROGESTERONE ACETATE

Brand Name : PROVERA 10MG TABLETS

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100

Approval Date :

Application Number : 729973

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

04

PFIZER CANADA ULC

AAPS 2024

Not Confirmed

PFIZER CANADA ULC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEDROXYPROGESTERONE ACETATE

Brand Name : PROVERA 5MG TABLETS

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100

Approval Date :

Application Number : 30937

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

05

Pharmascience Inc.

AAPS 2024

Not Confirmed

Pharmascience Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Medroxyprogesterone Acetate

Brand Name : PMS-MEDROXYPROGESTERONE

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

06

Pharmascience Inc.

AAPS 2024

Not Confirmed

Pharmascience Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Medroxyprogesterone Acetate

Brand Name : PMS-MEDROXYPROGESTERONE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

07

Pharmascience Inc.

AAPS 2024

Not Confirmed

Pharmascience Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Medroxyprogesterone Acetate

Brand Name : PMS-MEDROXYPROGESTERONE

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

08

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEDROXYPROGESTERONE ACETATE

Brand Name : TEVA-MEDROXYPROGESTERONE

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 100/500/1000

Approval Date :

Application Number : 2221284

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEDROXYPROGESTERONE ACETATE

Brand Name : TEVA-MEDROXYPROGESTERONE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500/1000

Approval Date :

Application Number : 2221292

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEDROXYPROGESTERONE ACETATE

Brand Name : TEVA-MEDROXYPROGESTERONE

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100/500/1000

Approval Date :

Application Number : 2221306

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?